These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9888029)

  • 1. Outpatient parenteral antimicrobial therapy for osteomyelitis.
    Tice AD
    Infect Dis Clin North Am; 1998 Dec; 12(4):903-19. PubMed ID: 9888029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outpatient parenteral antibiotic therapy (OPAT)].
    Štefan M; Holub M
    Cas Lek Cesk; 2016; 155(3):21-4. PubMed ID: 27256144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral antibiotic therapy: principles and practice.
    Seaton RA; Barr DA
    Eur J Intern Med; 2013 Oct; 24(7):617-23. PubMed ID: 23602223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children.
    Maraqa NF; Gomez MM; Rathore MH
    J Pediatr Orthop; 2002; 22(4):506-10. PubMed ID: 12131449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
    Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
    Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries.
    Tice A
    Chemotherapy; 2001; 47 Suppl 1():5-16. PubMed ID: 11096184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of a veterans affairs outpatient antimicrobial treatment program.
    Mohammadi S; MacKay K; Ward TT; Forrest GN
    South Med J; 2013 Jun; 106(6):345-9. PubMed ID: 23736174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effectiveness of flucloxacillin delivery using an elastomeric device for outpatient parenteral antimicrobial therapy.
    Zhang Y; Ody YC; Davis L
    Br J Community Nurs; 2020 Aug; 25(8):376-380. PubMed ID: 32772722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment of osteomyelitis with telavancin.
    Schroeder CP; Van Anglen LJ; Dretler RH; Adams JS; Prokesch RC; Luu Q; Krinsky AH
    Int J Antimicrob Agents; 2017 Jul; 50(1):93-96. PubMed ID: 28456704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    Nathwani D
    J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost.
    Bernard L; El-Hajj ; Pron B; Lotthé A; Gleizes V; Signoret F; Denormandie P; Gaillard JL; Perronne C
    J Clin Pharm Ther; 2001 Dec; 26(6):445-51. PubMed ID: 11722682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcomes of pyogenic vertebral osteomyelitis requiring spinal instrumentation.
    Park KH; Cho OH; Bae IG; Lee MS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):7021. PubMed ID: 25324233
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient selection in outpatient parenteral antimicrobial therapy.
    Nolet BR
    Infect Dis Clin North Am; 1998 Dec; 12(4):835-47, v-vi. PubMed ID: 9888025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to "therapeutic outcomes of pyogenic vertebral osteomyelitis requiring spinal instrumentation".
    Arnold R; Rock C; Croft L; Gilliam BL; Morgan DJ
    Antimicrob Agents Chemother; 2014 Nov; 58(11):7022. PubMed ID: 25324234
    [No Abstract]   [Full Text] [Related]  

  • 15. [Daptomycin in home hospitalization].
    González Ramallo VJ
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():48-54. PubMed ID: 21477704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.
    Upton A; Ellis-Pegler RB; Woodhouse A
    N Z Med J; 2004 Aug; 117(1200):U1020. PubMed ID: 15475990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
    Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
    Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Daptomycin in outpatient antimicrobial parenteral therapy].
    Cervera C; Mestres CA
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():59-63. PubMed ID: 22541978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.